Combination Covid, flu shot race is heating up
A health care worker prepares an injection of Pfizer’s Covid-19 vaccine Comirnaty, Sept. 14, 2023. Irfan Khan | Los Angeles Times | Getty Images A version of this article first …
BioNTech SE
Moderna (MRNA) earnings Q2 2024
The Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on Thursday reported second-quarter revenue that beat expectations but …
Pfizer 2024 revenue, profit forecast disappoints
Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it sees weak demand for its once-blockbuster Covid products. Pfizer also raised …
Stocks making the biggest moves midday: TSLA, DIS, BABA, ULTA
Check out the companies making headlines in midday trading. Tesla — Tesla shares slipped less than 1% as Wall Street assessed the company’s long-anticipated Cybertruck following a delivery launch event …
Pfizer combination Covid, flu vaccine shows positive trial data
CFOTO | Future Publishing | Getty Images Pfizer on Thursday said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months …
LULU, PFE, NWSA, SCHW and more
Check out the companies making the biggest moves midday. Lululemon — Shares of the athleisure clothing company surged more than 10% after S & P Dow Jones Indices announced that …
Moderna combination Covid, flu vaccine shows positive data
Artur Widak | Nurphoto | Getty Images Moderna on Wednesday said its combination vaccine targeting Covid and the flu will move to a final stage trial in adults ages 50 …
Covid vaccine stocks jump as new variants emerge
Nikos Pekiaridis | Lightrocket | Getty Images Covid vaccine makers’ shares rose Monday as new variants of the virus emerge in the U.S. ahead of the rollout of updated shots …
GSK sues Pfizer claiming RSV vaccine patent infringement
Jun Li | Istock | Getty Images GlaxoSmithKline on Wednesday sued Pfizer in U.S. court, alleging patent infringement over Britain-based GSK’s respiratory syncytial virus vaccine. GSK claims New York-based Pfizer’s …